BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:15 PM
 | 
Sep 28, 2009
 |  BC Extra  |  Company News

Abbott to acquire Solvay's pharma unit

Abbott Laboratories (NYSE:ABT) will acquire partner Solvay Pharmaceuticals Inc., a unit of Solvay S.A. (Euronext:SOLB), for EUR 4.5 billion ($6.6 billion) in cash and up to...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >